Follow the Immutep Limited stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are quoted on AU AU, under the authority of ASX. Operating in the Health Care sector, Immutep Limited has logged 4 public disclosures. Market capitalisation: €78.1m. The latest transaction was reported on 10 May 2026 (Cease Substantial Holding). Among the most active insiders: There was a change in the interests of the. The full history is openly available.
Analysts rate Immutep Limited Hold (neutral), based on 3 analysts. Average price target: A$0.10.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations